跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12 条关于
“ZYMFENTRA”
全部
12
临床试验
1
药物
0
机构
0
资讯
11
前天
Celltrion Launches U.S. Phase 4 Trial of 240mg High-Dose Zymfentra in Crohn's and Ulcerative Colitis
去年
Celltrion to Present New ZYMFENTRA® Data for IBD Management at 2025 Digestive Disease Week
去年
Celltrion's Ustekinumab Biosimilar SteQeyma Approved in Europe; Zymfentra Access Expands
9个月前
ZYMFENTRA Shows Consistent Efficacy Across Crohn's Disease Locations in Post-Hoc Analysis of LIBERTY-CD Study
去年
Prometheus Laboratories Partners with Celltrion to Validate Therapeutic Drug Monitoring for Subcutaneous Infliximab
去年
Infliximab Monotherapy Shows Comparable Efficacy to Combination Therapy in IBD Treatment
9个月前
Celltrion's Autoimmune Biosimilar Avtozma Gains Preferred Status with Major U.S. Pharmacy Benefit Manager
去年
CT-P13 Subcutaneous Formulation Shows Comparable Pharmacokinetics and Safety via Autoinjector and Pre-filled Syringe
去年
Infliximab Maintains Efficacy in Crohn's Disease and Ulcerative Colitis Regardless of Immunosuppressant Use
9个月前
Celltrion Internalizes Hyaluronidase-Based Subcutaneous Formulation Technology to Expand Biosimilar Pipeline
第 1 页,共 2 页
上一页
下一页